Bristol-Myers Squibb Company: Diferență între versiuni

Pagina dedicata companiei Bristol-Myers Squibb Company listata cu simbolul US.BMY

Descriere companie

Bristol-Myers Squibb Company (www.bms.com) is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.

Ultimele stiri despre Bristol-Myers Squibb Company (US.BMY)

• Neutralitatea climatica costa scump - 10 octombrie 2023
• Bristol Myers Sues AstraZeneca Over PD-L1 Cancer Drug Patents - 23 martie 2022
• Bristol-Myers Squibb Company